Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators episode artwork

EPISODE · Feb 18, 2026 · 57 MIN

Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

from Oncology Today with Dr Neil Love

Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.CME information and select publications here.

Episode metadata supplied by the publisher feed · Published Feb 18, 2026

Embed this episode

NOW PLAYING

Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

0:00 57:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Today with Dr Neil Love?

This episode is 57 minutes long.

When was this Oncology Today with Dr Neil Love episode published?

This episode was published on February 18, 2026.

Can I download this Oncology Today with Dr Neil Love episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!